- Home
- INTS vs FGI Comparison
INTS vs FGI Comparison
Compare INTS & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- FGI
- Stock Information
- Founded
- INTS 2012
- FGI 1987
- Country
- INTS United States
- FGI United States
- Employees
- INTS N/A
- FGI N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- FGI Industrial Specialties
- Sector
- INTS Health Care
- FGI Industrials
- Exchange
- INTS Nasdaq
- FGI Nasdaq
- Market Cap
- INTS 12.2M
- FGI 10.4M
- IPO Year
- INTS 2023
- FGI 2022
- Fundamental
- Price
- INTS $0.62
- FGI $5.36
- Analyst Decision
- INTS Strong Buy
- FGI
- Analyst Count
- INTS 4
- FGI 0
- Target Price
- INTS $4.50
- FGI N/A
- AVG Volume (30 Days)
- INTS 85.6M
- FGI 923.9K
- Earning Date
- INTS 11-17-2025
- FGI 11-05-2025
- Dividend Yield
- INTS N/A
- FGI N/A
- EPS Growth
- INTS N/A
- FGI N/A
- EPS
- INTS N/A
- FGI N/A
- Revenue
- INTS N/A
- FGI $135,904,413.00
- Revenue This Year
- INTS N/A
- FGI $5.57
- Revenue Next Year
- INTS N/A
- FGI $8.02
- P/E Ratio
- INTS N/A
- FGI N/A
- Revenue Growth
- INTS N/A
- FGI 12.30
- 52 Week Low
- INTS $0.19
- FGI $2.28
- 52 Week High
- INTS $3.40
- FGI $12.62
- Technical
- Relative Strength Index (RSI)
- INTS 57.24
- FGI 48.41
- Support Level
- INTS $0.23
- FGI $4.93
- Resistance Level
- INTS $1.74
- FGI $5.60
- Average True Range (ATR)
- INTS 0.14
- FGI 0.59
- MACD
- INTS 0.06
- FGI -0.09
- Stochastic Oscillator
- INTS 25.69
- FGI 32.41
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.